Identification of Lower Grade Glioma Antigens Based on Ferroptosis Status for mRNA Vaccine Development.
Zhenxiang ZhaoNa XingHao GuoJianfeng LiGuozhu SunPublished in: Pharmacogenomics and personalized medicine (2024)
HOTAIR, IDO1, KIF20A, NR5A2, and RRM2 were identified as promising candidate antigens for the development of an LGG mRNA vaccine, particularly offering potential benefits to FS2 and FS4 patients.